TRAIL-Mediated Apoptosis in Human Liver Chang Cells. 2003

Channy Park, and Sung Wook Hong, and Sung Ho Jin, and Nam Song Kim, and Kyung Ho Cho, and Jin Ho Cheon, and Jae Yeon Ahn, and Jung Ku Yang, and Raekil Park

OBJECTIVE Tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL)/APO-2L is a member of the TNF family that can kill a wide variety of tumor cells, but not normal cells. This study was designed to investigate the down stream target proteins in TRAIL-mediated apoptosis of human liver, Chang cells. METHODS The expressions of DR4/DR5 in hepatoma cells, including Chang, HepG2 and Hep3B cells, were determined by RT-PCR. Cell viability was measured by MTT assay and apoptosis was assessed by DNA fragmentation assay. The catalytic activity of caspase- family proteases, including caspase-3 and -9, was tested by using fluorogenic biosubstrates. Expression of apoptotic mediators, including procaspase-3 and PARP proteins, was measured by Western blotting. The expression profile of proteins in Chang cells by using two-dimensional (2-D) gel electrophoresis and MALDI-TOF. RESULTS The results demonstrated that TRAIL (100 ng/ml) induced the apoptotic death of Chang cells, as characterized by the ladder-pattern fragmentation of genomic DNA. TRAIL increased the enzymatic activity of caspase- 3, corresponding to the time of appearance of cleaved PARP and caspase-9. In 2-D gel electrophoresis and MALDI- TOF analysis, the comparison of control versus apoptotic cells in the protein expressions revealed that signal intensity of 7 spots were decreased, whereas 6 spots were increased among 300 spots. These spots were resolved and identified as a protein information by MALDI-TOF. CONCLUSIONS We suggested that TRAIL induces the apoptotic death of Chang cells via proteome alterations inducing caspase cascade.

UI MeSH Term Description Entries

Related Publications

Channy Park, and Sung Wook Hong, and Sung Ho Jin, and Nam Song Kim, and Kyung Ho Cho, and Jin Ho Cheon, and Jae Yeon Ahn, and Jung Ku Yang, and Raekil Park
August 2001, Surgery,
Channy Park, and Sung Wook Hong, and Sung Ho Jin, and Nam Song Kim, and Kyung Ho Cho, and Jin Ho Cheon, and Jae Yeon Ahn, and Jung Ku Yang, and Raekil Park
January 2004, Cancer genomics & proteomics,
Channy Park, and Sung Wook Hong, and Sung Ho Jin, and Nam Song Kim, and Kyung Ho Cho, and Jin Ho Cheon, and Jae Yeon Ahn, and Jung Ku Yang, and Raekil Park
January 2001, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,
Channy Park, and Sung Wook Hong, and Sung Ho Jin, and Nam Song Kim, and Kyung Ho Cho, and Jin Ho Cheon, and Jae Yeon Ahn, and Jung Ku Yang, and Raekil Park
January 2001, Anticancer research,
Channy Park, and Sung Wook Hong, and Sung Ho Jin, and Nam Song Kim, and Kyung Ho Cho, and Jin Ho Cheon, and Jae Yeon Ahn, and Jung Ku Yang, and Raekil Park
January 2009, Clinical cancer research : an official journal of the American Association for Cancer Research,
Channy Park, and Sung Wook Hong, and Sung Ho Jin, and Nam Song Kim, and Kyung Ho Cho, and Jin Ho Cheon, and Jae Yeon Ahn, and Jung Ku Yang, and Raekil Park
January 2018, PloS one,
Channy Park, and Sung Wook Hong, and Sung Ho Jin, and Nam Song Kim, and Kyung Ho Cho, and Jin Ho Cheon, and Jae Yeon Ahn, and Jung Ku Yang, and Raekil Park
July 1997, Biochemical and biophysical research communications,
Channy Park, and Sung Wook Hong, and Sung Ho Jin, and Nam Song Kim, and Kyung Ho Cho, and Jin Ho Cheon, and Jae Yeon Ahn, and Jung Ku Yang, and Raekil Park
February 1976, Annals of the rheumatic diseases,
Channy Park, and Sung Wook Hong, and Sung Ho Jin, and Nam Song Kim, and Kyung Ho Cho, and Jin Ho Cheon, and Jae Yeon Ahn, and Jung Ku Yang, and Raekil Park
February 2006, Journal of immunology (Baltimore, Md. : 1950),
Channy Park, and Sung Wook Hong, and Sung Ho Jin, and Nam Song Kim, and Kyung Ho Cho, and Jin Ho Cheon, and Jae Yeon Ahn, and Jung Ku Yang, and Raekil Park
June 2012, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!